Previous 10 | Next 10 |
home / stock / nvsef / nvsef news
The following slide deck was published by Novartis AG in conjunction with this event. For further details see: Novartis (NVS) Iptacopan (LNP023) Update - Slideshow
The Vanguard International High Dividend Yield ETF is a decent investment, but it is not a vehicle to achieve "high yield". According to my math, the LTM distributions equate to a 2.88% yield. But before you turn away, VYMI's one-year total returns are an impressive 45.5% (yes, as...
AstraZeneca's innovative culture earned it a place as one of the leading biotechs globally. Revenue growth from COVID vaccine sales and some key markets provide strong tailwinds for the company's share in the second half of 2021. Most of AstraZeneca's revenue comes from a handful ...
This technology-focused healthcare infrastructure platform connects payors, providers, and employers in an efficient and analytical way. As a new growth-based company seeing 40% CAGR revenues over the past two years, net income remains negative but profitability is higher than their p...
Novartis AG (NVS) Cardiovascular Update Call May 18, 2021, 11:30 ET Company Participants Samir Shah - Global Head, IR David Soergel - Head, Cardiovascular, Renal & Metabolic Development Group Rod Wooten - Global Head, Marketing of Novartis Pharmaceuticals Victor Bulto - Head, US Pharmaceu...
Kahn Brothers’ 13F portfolio value increased from $579M to $646M this quarter. Stakes in VOXX International and BlackBerry were decreased during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~45% of the 13F holdings....
Healthcare offers essential services that people can't go without, recession or not. The Tekla funds can offer potential in any one of their funds for healthcare exposure. Today we explore the differences and the similarities of the funds. For further details see: Tekla ...
ARKG’s Sharpe Ratio and outperformance suggest great stock-picking by the fund manager. However, the neutral rating is premised on a long-term time horizon for value realization in view of ARKG’s rich valuation. Furthermore, the general market is not unequivocally ri...
Fisher’s 13F portfolio value increased from ~$133.5B to ~$142B in Q1 2021. They increased Walt Disney and Eli Lilly while trimming Taiwan Semi, JD.com, and Pinduoduo. Fisher has a number of small positions in several ETFs/ETNs. For further details see: Tracking Ke...
Novartis AG (NVS) Q1 2021 Earnings Conference Call April 27, 2021 8:00 AM ET Company Participants Samir Shah – Global Head-Investor Relations Vas Narasimhan – Chief Executive Officer Marie-France Tschudin – President-Novartis Pharmaceuticals Richard Saynor – Chief ...
News, Short Squeeze, Breakout and More Instantly...
Novartis Ag Basel Akt Company Name:
NVSEF Stock Symbol:
OTCMKTS Market:
Novartis Ag Basel Akt Website:
FDA approval of the company’s second US Radioligand Therapy (RLT) manufacturing facility increases RLT production capacity to 250,000 doses in 2024 and beyond New 70,000-square foot RLT facility is the company’s largest and most advanced in the world to date and centrall...
APPLY-PNH extension data show that continuous Fabhalta ® (iptacopan) treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH) enabled sustained hemoglobin-level increases to near-normal (≥12 g/dL), blood transfusion avoidance, and improved patient-reported fatigu...
With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali ® (ribociclib) investigational treatment, the updated analysis shows sustained iDFS benefit and stability in secondary endpoints including overall survival (OS) 1,2 iDFS...